venBio Global Strategic Fund II L.P. 13D and 13G filings for Checkmate Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-06-07 4:15 pm Sale | 2022-05-31 | 13G | Checkmate Pharmaceuticals, Inc. CMPI | venBio Global Strategic Fund II L.P. | 0 0.000% | -2,535,158 (Position Closed) | Filing |
| 2022-05-05 4:15 pm Sale | 2022-05-03 | 13G | Checkmate Pharmaceuticals, Inc. CMPI | venBio Global Strategic Fund II L.P. | 2,535,158 11.500% | -1,138,216 (-30.99%) | Filing |
| 2020-10-06 3:19 pm Purchase | 2020-08-11 | 13G | Checkmate Pharmaceuticals, Inc. CMPI | venBio Global Strategic Fund II L.P. | 3,673,374 17.100% | 3,673,374 (New Position) | Filing |